read more

first_img News | Focused Ultrasound Therapy | July 10, 2019 Insightec’s Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s… read more Related Content Technology | Interventional Radiology | August 16, 2019 Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to… read more Nationwide Childrens Hospital installs a new combined operative and diagnostic MRI suite. News | April 06, 2010 Children’s Hospital Opens Operative, Diagnostic MRI Suite April 6, 2010 – To optimize the use of its magnetic resonance imaging (MRI) system, Nationwide Children’s Hospital is unveiling a new combined operative and diagnostic MRI suite. This unfixed MRI system can move between three different rooms, allowing physicians to utilize the machine for intraoperative MRI diagnostics and non-operative diagnostic imaging. One of a few MRI’s in the U.S. to be used this three-room design, the set up includes a central room for housing the magnet and two adjoining rooms, into which the magnet can be transported.The intraoperative MRI allows neurosurgeons to scan for the presence of a remaining tumor during a tumor-removal operation, reducing the chance of leaving a portion of tumor. In addition, the MRI suite is located near the operating room, which increases access for the anesthesia team as anesthesia is required for a pediatric patient undergoing an MRI scan. According to the hospital, due to the close proximity of the MRI to the operating room, the number of patients who can be seen during an eight-hour period is doubled and this additional system will increase volume capacity by 20 percent. The hospitals expects both radiology and neurosurgery patients to benefit from this combined MRI suite. For more information: www.nationwidechildrens.org FacebookTwitterLinkedInPrint分享 Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al. News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor FDA Issues Draft Guidance on Medical Device Safety in MRI Environment The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for… read more center_img News | Magnetic Resonance Imaging (MRI) | August 06, 2019 Canon Medical Introduces Encore Orian MR Upgrade Program Canon Medical Systems USA Inc. is helping to provide low-cost patient care solutions for its customers with the launch… read more Technology | Neuro Imaging | August 07, 2019 Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release… read more News | Neuro Imaging | August 16, 2019 ADHD Medication May Affect Brain Development in Children A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s… read more News | Image Guided Radiation Therapy (IGRT) | July 16, 2019 AAPM 2019 Features More Than 40 Presentations on ViewRay’s MRIdian MRI-guided Radiotherapy ViewRay Inc. announced that the company’s MRIdian System is the focus of more than 40 abstracts selected by the… read more Technology | Contrast Media | July 15, 2019 FDA Approves Bayer’s Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance… read more Feature | Contrast Media | July 18, 2019 | By Greg Freiherr How To Manage Risk in the MR Suite Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n read more News | Neuro Imaging | July 05, 2019 Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American… read morelast_img

Leave a Reply

Your email address will not be published. Required fields are marked *